Enveric Biosciences Plans About 35 Percent Reduction In Full-time Personnel

RTTNews | 534 days ago
Enveric Biosciences Plans About 35 Percent Reduction In Full-time Personnel

(RTTNews) - Biotechnology company Enveric Biosciences, Inc. (ENVB) announced Monday a cost reduction plan resulting in approximately 40% to 55% decrease in expenses and extension of financial runway into the first quarter of 2024.

The operational streamlining entailed an approximately 35 percent reduction in full-time personnel, the cancelation of 7 consulting contracts focused on the cannabinoid programs and a transition from third-party service providers supporting R&D efforts to internal science teams performing this work.

The company also announced the termination of proposed spin-off of cannabinoid clinical development pipeline to a publicly traded company, Akos Biosciences, Inc. Enveric is now engaging with strategic advisors to identify and pursue alternative value-creating opportunities for cannabinoid assets.

read more
Canadian Market Slightly Lower In Cautious Trade

Canadian Market Slightly Lower In Cautious Trade

Canadian stocks are turning in a mixed performance on Wednesday with investors largely reacting to earnings announcements, and U.S. economic data. Materials stocks are among the notable losers, while consumer staples and utilities shares are finding good support.
RTTNews | 4h 43min ago
Swiss Market Ends Notably Lower

Swiss Market Ends Notably Lower

The Switzerland market ended notably lower on Wednesday after languishing in negative territory right through the day's session, as investors reacted to weak economic data, digested a slew of corporate earnings announcements, and looked ahead to some key U.S. economic data due later in the week.
RTTNews | 5h 29min ago
U.S. Dollar Retreats As GDP Growth Slows

U.S. Dollar Retreats As GDP Growth Slows

The U.S. dollar pulled back against its major counterparts in the New York session on Wednesday, as a slowdown in GDP growth outweighed optimism about strong ADP data.
RTTNews | 5h 41min ago
U.S. Pending Home Sales Spike Much More Than Expected In September

U.S. Pending Home Sales Spike Much More Than Expected In September

Pending home sales in the U.S. spiked by much more than expected in the month of September, according to a report released by the National Association of Realtors on Wednesday. NAR said its pending home sales index soared by 7.4 percent to 75.8 in September after climbing by 0.6 percent to 70.6 in August. Economists had expected pending home sales to jump by 1.1 percent.
RTTNews | 8h 55min ago
GSK Q3 Results Down, Sees FY24 Outlook At Mid Range; Stock Drops

GSK Q3 Results Down, Sees FY24 Outlook At Mid Range; Stock Drops

Shares of GSK plc were losing more than 4 percent on the London Stock Exchange as well as in the early morning trading on the NYSE after the British drug maker reported Wednesday sharply lower profit in its third quarter on $2.3 billion charge on Zantac settlement, as well as weak revenues. Further, GSK confirmed its fiscal 2024 outlook for earnings, core profit and sales.
RTTNews | 9h 27min ago